Astellas and Twist team up in antibodies; FDA asks DBV for an additional safety study in peanut allergy patch
Astellas will license Twist Bioscience’s VHH antibody libraries for five years to conduct R&D, Twist announced Thursday. The deal includes an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
